• Sponsored Content

Process Innovation Leads to More Affordable Biosimilars

Sarfaraz Niazi

August 15, 2014

2 Min Read

Biosimilars are set to dramatically improve how millions of people access expensive, complex, life-saving treatments by providing equally effective alternatives to innovator products while lessening the cost burden (>30%). Therapeutic Proteins International, LLC (TPI) is a fully integrated manufacturer of biosimilar recombinant protein products that has reinvented conventional approaches to biologic drug manufacturing.

Powerful Science Shouldn’t Be Complicated

TPI has reinvented the process used to manufacture biological drugs making it simpler by leveraging superior technology and rigorous scientific methods to significantly reduce the number of steps involved. At the core of TPI’s patented manufacturing platform are disposable bioreactors and a totally single-use system. Those proprietary systems allow for quick scale up and simultaneous development, which reduce the timeline and costs associated with bringing products to market. In addition, TPI performs analytics at each step to optimize performance and aim for high quality, fingerprint-like similarity. BPI_A_141207AR26_O_F0001g-150x150.jpg

TPI’s fully integrated process, characterization expertise, analytical frameworks, and end-to-end process allows TPI to quickly respond to the evolving regulatory requirements of the biosimilar environment, while creating competitive advantages through practical and efficient solutions.Located in Chicago, IL, TPI is exclusively focused on developing and manufacturing biosimilar products. Nine of such products are currently in the company’s development pipeline for launch in the United States, Europe, and other countries starting in 2015.

The TPI Team

Sarfaraz K. Niazi, PhD, is an architect of and a leading authority on today’s biological drug industry. As founder, chairman, and CEO of Therapeutic Proteins International, he has set out to revolutionize the way drugs are made to enable access to high-quality, life-altering drugs at an affordable cost to all those that need them.Dr. Niazi handpicked TPI’s senior leadership team to include talented and seasoned industry leaders recognized for their unique depth and breadth of knowledge, exceptional analytical abilities, and commitment to quality. They have served various segments of the healthcare industry from leading global pharmaceutical and healthcare organizations.

For more information about Therapeutic Proteins International, visit our website at www.theraproteins.com or call 1-312-620-1500.

Dr. Sarfaraz K. Niazi is chairman and CEO of Therapeutic Proteins International, 3440 S. Dearborn Street, Suite 300, Chicago, IL 60616; 1-312-620-1500; fax 1-312-577-0698; [email protected].

You May Also Like